Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Pediatr Obes ; 12(1): e1-e5, 2017 02.
Artigo em Inglês | MEDLINE | ID: mdl-26843446

RESUMO

BACKGROUND: Investigations on sugar-sweetened beverage (SSB) intake and cardiometabolic risks among Asians are scant. OBJECTIVES: This study aimed to examine associations between SSB intake and cardiometabolic risks among Malaysian adolescents. METHODS: Anthropometric data, blood pressure (BP), fasting blood glucose (FBG), lipid profiles and insulin levels measured involved 873 adolescents (aged 13 years). SSB intake, dietary patterns and physical activity level (PAL) were self-reported. RESULTS: Mean SSB consumption was 177.5 mL day-1 with significant differences among ethnicities (Malay, Chinese, Indians and Others) (p < 0.05). SSB intake was deleteriously associated with increased waist circumference, elevated triglycerides, FBG, insulin, insulin resistance and low HDL-cholesterol, independent of PAL, body mass index and dietary patterns. Significant U-shaped and inverse trends were noted between SSB intake and LDL-cholesterol and BP, respectively. CONCLUSION: Sugar-sweetened beverage intake was unfavourably associated with cardiometabolic health outcomes among young adolescents. Concerted efforts towards healthy hydration are imperative to mitigate risk of cardiometabolic events.


Assuntos
Bebidas/efeitos adversos , Sacarose Alimentar/efeitos adversos , Comportamento Alimentar , Síndrome Metabólica/etiologia , Adolescente , Antropometria , Glicemia/análise , Pressão Sanguínea , Estudos Transversais , Exercício Físico , Feminino , Humanos , Insulina/sangue , Lipídeos/sangue , Malásia , Masculino , Síndrome Metabólica/epidemiologia , Fatores de Risco
2.
Transplant Proc ; 48(1): 81-7, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-26915847

RESUMO

BACKGROUND: The aim of this study was to compare the within-patient variability trough levels (Co), dose-adjusted Co, and dose requirements of Prograf and Advograf with CYP3A5 polymorphisms in Malaysia renal transplant recipients. METHODS: Stable post-renal transplantation patients switched from Prograf to Advograf were retrospectively identified from University Malaya Medical Centre (n = 28). Co and concomitant tacrolimus dose 6 months preconversion and postconversion were examined. CYP3A5 was genotyped using reverse transcriptase polymerase chain reaction. Wilcoxon signed rank test and Mann-Whitney U test were used to compare Co and dose between formulations and according to genotypes. RESULTS: There was a significant difference in the whole-blood tacrolimus Co between the 2 groups (6.16 ± 1.74 ng/mL vs 4.90 ± 1.06 ng/mL; P = .0001). The mean daily maintenance dose of Prograf was 3.9 ± 2.0 mg/kg (0.06 mg/kg/d), which was reduced to 3.3 ± 1.7 mg/d (0.04 mg/kg/d) with Advograf (P = .01). The mean maintenance dose of tacrolimus required for those with CYP3A5*1/*1 (high-expressive) was significantly higher than those with CYP3A5*1/*3 (intermediate-expressive) and CYP3A5*3/*3 (low-expressive) (P < .01) for both formulations. Comparing those with CYP3A5*1/*1, the average dose-adjusted Co was significantly higher in patients with CYP3A5*3/*3 with Advograf (P < .05). CONCLUSIONS: The requirement for daily maintenance dose was higher in those with CYP3A5*1/*1 variants in both tacrolimus formulations in the Malaysian patients. Furthermore, those with CYP3A5*3/*3 demonstrated significantly higher dose-adjusted Co with Advograf.


Assuntos
Citocromo P-450 CYP3A/genética , Imunossupressores/farmacocinética , Transplante de Rim , Polimorfismo Genético , Tacrolimo/farmacocinética , Adulto , Idoso , Povo Asiático/genética , Relação Dose-Resposta a Droga , Feminino , Genótipo , Humanos , Malásia , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos
3.
Child Care Health Dev ; 41(6): 1216-26, 2015 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-25873448

RESUMO

BACKGROUND: Physical functioning and psychological resilience in adulthood is shaped during adolescence. Self-reported health-related quality of life (HRQoL) assessments during this life phase are important first-hand accounts of their well-being. This study aimed, firstly, to identify differences in HRQoL according to gender, ethnicity, socio-economic status and weight status; and secondly, to examine associations between weight status and HRQoL among an urban sample of multi-ethnic adolescents in Kuala Lumpur, Malaysia. METHODS: A cross-sectional study involving 652 adolescents (aged 13 years) was conducted in Kuala Lumpur. Weight and height were measured. Body mass index z-scores were categorized according to the International Obesity Task Force criteria. HRQoL was assessed using the Malay version of the Pediatric Quality of Life Inventory 4.0 Generic Core Scales. Univariate analyses of differences in HRQoL according to gender, ethnicity (Malays, Chinese and Indians), maternal education level and weight status were performed. Complex samples general linear model was used to examine the associations between HRQoL and weight status, adjusted for confounders. RESULTS: Female adolescents reported significantly lower emotional functioning scores (mean, 95% confidence interval: 59.25, 57.33-61.17). When the three main ethnic groups were studied, Malay adolescents scored significantly lower emotional functioning scores (59.00, 57.13-60.87) compared with their Chinese peers. Adolescents with tertiary-educated mothers reported lower emotional functioning scores (57.45, 53.85-61.06) compared with those with primary-educated mothers. Obese adolescents reported poorer HRQoL scores with significantly impaired physical and social functioning after controlling for confounders. CONCLUSIONS: These findings detected disparities in HRQoL among the adolescents when gender, ethnicity, maternal education level and weight status were considered. Further studies should address these health inequalities by implementing gender-specific and culturally appropriate measures to attain optimal well-being and avoid potential burden of disease.


Assuntos
Disparidades nos Níveis de Saúde , Qualidade de Vida , Adolescente , Peso Corporal , Estudos Transversais , Países em Desenvolvimento , Etnicidade , Feminino , Humanos , Malásia , Masculino , Fatores de Risco , Fatores Sexuais , Fatores Socioeconômicos , População Urbana
4.
Ir J Med Sci ; 183(2): 311-8, 2014 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-24013870

RESUMO

BACKGROUND: Over the last decade there have been significant changes in the prescribing of antidiabetic therapies. It is of interest to know about these trends and variations in the Irish population so that future prescribing patterns can be estimated. AIMS: To examine the trends in prescribed antidiabetic treatments, including variations across age, gender, socioeconomic status and regions in the Irish population over the last 10 years. METHODS: The Irish national pharmacy claims database was used to identify patients ≥ 16 years dispensed antidiabetic agents (oral or insulin) from January 2003 to December 2012 through the two main community drug schemes for diabetes. The rate of prescribing per 1,000 population was calculated. Logistic regression was used to examine variations in prescribing in patients with diabetes. RESULTS: There was a significant increase in the prescribing of fast and long-acting insulin analogues with a rapid decline in the prescribing of human insulin (p < 0.0001). Increased prescribing of metformin, incretin modulators and fixed oral combination agents was observed (p < 0.0001). Females and older aged patients were more likely to be prescribed human insulin than other insulins. Metformin was less likely while sulphonylureas were more likely to be prescribed in older than younger aged patients. Socioeconomic differences were observed in increased prescribing of the newer and more expensive antidiabetic agents in the non-means tested scheme. Regional variations were observed in the prescribing of both insulin and oral antidiabetic agents. CONCLUSION: There has been an increase over time in the prescribing of both insulin and oral antidiabetic agents in the Irish population with increasing uptake of newer antidiabetic agents. This has implications for projecting future uptake and expenditure of these agents given the rising level of diabetes in the population.


Assuntos
Diabetes Mellitus/tratamento farmacológico , Hipoglicemiantes/uso terapêutico , Insulina/uso terapêutico , Fatores Etários , Idoso , Bases de Dados Factuais , Prescrições de Medicamentos , Feminino , Humanos , Incretinas/uso terapêutico , Irlanda , Masculino , Metformina/uso terapêutico , Pessoa de Meia-Idade , Fatores Sexuais , Adulto Jovem
5.
Pharmacoepidemiol Drug Saf ; 20(9): 979-86, 2011 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-21774032

RESUMO

PURPOSE: To examine the impact of safety warnings issued between 2005 and 2007 by the Irish Medicines Board (IMB) on the rate of prescribing of clopidogrel, co-amoxiclav, celecoxib and haloperidol by primary care physicians in the General Medical Services (GMS) scheme across Ireland. METHODS: This study was performed using the Irish Health Service Executive-Primary Care Reimbursement Services national prescribing database. Rate of prescribing per 1000 GMS population was calculated for each of the 12 months before and after the IMB warnings were issued to physicians. A segmented regression analysis was used to examine the change in level and trend in prescribing rates before and after the IMB warnings. Regression coefficients are presented with SEs. Significance at p < 0.05 was assumed. SPSS 16 and SAS were used for statistical analysis. RESULTS: Prescribing of clopidogrel continued to rise in both genders following the warning. This increase was slightly higher in male patients. The prescribing of co-amoxiclav showed seasonal variation with significant autocorrelation. The rate of prescribing of celecoxib declined approximately 4 months prior to the IMB warning. A significant decrease in the level and trend of the rate of prescribing of celecoxib was observed with evident discontinuity. The IMB warning had no significant effect on the level of trend in the prescribing of haloperidol, suggesting no discontinuity. CONCLUSIONS: Results indicate that the IMB safety warnings had inconsistent effects on the rate of prescribing of drugs considered.


Assuntos
Rotulagem de Medicamentos , Padrões de Prática Médica , Prescrições de Medicamentos/estatística & dados numéricos , Revisão de Uso de Medicamentos/tendências , Humanos , Irlanda
6.
Ir J Med Sci ; 178(4): 413-7, 2009 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-19838641

RESUMO

BACKGROUND: Hypertension is the commonest medical condition in Ireland. AIMS: (1) To examine the level of awareness of blood pressure (BP) in the population and (2) to ascertain the opinion of general practitioners (GPs) in diagnosis and management of hypertension. METHODS: BP measurements and assessment of BP awareness were performed in a sub-sample of the general population (n = 1,071). The opinion of GPs (n = 1,037) on hypertension was determined in a postal survey. RESULTS: Amongst the population sampled (45 ± 13 years, mean age ± SD), almost half had elevated BP (>140/90 mmHg) but only half of those were already on antihypertensives. 40% had no knowledge of their BP and 54% were not aware of what constituted normal BP. While some 80% of GPs said they followed British guidelines, their practice was more in keeping with the European guidelines. Approximately, 90% of GPs required ambulatory BP recording to confirm diagnosis of hypertension. First choice antihypertensive agents were ACE inhibitors and angiotensin receptor antagonists in younger patients and diuretics and ACE inhibitors in older patients. CONCLUSION: These results suggest that there is a need for further public education on BP and nationally agreed hypertension guidelines.


Assuntos
Conhecimentos, Atitudes e Prática em Saúde , Hipertensão/tratamento farmacológico , Hipertensão/epidemiologia , Padrões de Prática Médica , Adulto , Antagonistas de Receptores de Angiotensina/uso terapêutico , Inibidores da Enzima Conversora de Angiotensina/uso terapêutico , Pressão Sanguínea , Diuréticos/uso terapêutico , Feminino , Fidelidade a Diretrizes , Humanos , Irlanda/epidemiologia , Masculino , Pessoa de Meia-Idade , Guias de Prática Clínica como Assunto
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...